Triple-negative breast cancer (TNBC) is defined by lack of ER (estrogen receptor) and PR (progesterone receptor) expression and HER2 (human epidermal growth factor receptor 2) overexpression (or HER2 gene amplification). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.